Possible Use of Non-purine Selective Xanthine Oxidoreductase Inhibitors for Prevention of Exercise-induced Acute Kidney Injury Associated with Renal Hypouricemia

Intern Med. 2023 Sep 15;62(18):2725-2730. doi: 10.2169/internalmedicine.0678-22. Epub 2023 Feb 8.

Abstract

Exercise-induced acute kidney injury (EIAKI) is frequently complicated with renal hypouricemia (RHUC). In patients with RHUC, limiting anaerobic exercise can prevent EIAKI. However, it is challenging to reduce exercise intensity in athletes. We herein report a 16-year-old Japanese football player with familial RHUC with compound heterozygous mutations in urate transporter 1 (URAT1) who presented with recurrent EIAKI. As prophylaxis (hydration during exercise) could not prevent EIAKI, febuxostat was initiated. EIAKI was not observed for 16 months despite exercising intensively. Hence, non-purine-selective xanthine oxidoreductase inhibitors may decrease the incidence of EIAKI in athletes with RHUC.

Keywords: athlete; exercise-induced acute kidney injury; febuxostat; renal hypouricemia; selective xanthine oxidoreductase inhibitor.

MeSH terms

  • Acute Kidney Injury* / etiology
  • Acute Kidney Injury* / prevention & control
  • Adolescent
  • Enzyme Inhibitors
  • Humans
  • Organic Anion Transporters* / genetics
  • Organic Cation Transport Proteins / genetics
  • Xanthine Dehydrogenase

Substances

  • Xanthine Dehydrogenase
  • Organic Anion Transporters
  • Organic Cation Transport Proteins
  • Enzyme Inhibitors

Supplementary concepts

  • Renal hypouricemia